301080.SZ
百普赛斯
SZSE · M 科研服务 · CN
CNY 92.63
−6.36%Year over year
Reported trailing growth
- Revenue
- +29.4%
- EBITDA
- —
- EBIT
- +28.0%
- EPS
- +30.5%
- Free cash flow
- +253.4%
- Operating cash flow
- +320.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +20.9%
- EBITDA
- -0.8%
- EBIT
- -7.8%
- Net income
- -6.7%
- EPS
- -16.5%
- Free cash flow
- +282.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026